Abstract:Luciferase-based bioluminescence detection techniques are highly favored in high-throughput screening (HTS), in which the firefly luciferase (FLuc) is the most commonly used variant. However, FLuc inhibitors can interfere with the activity of luciferase, which may result in false positive signals in HTS assays. In order to reduce the unnecessary cost of time and money, an in silico prediction model for FLuc inhibitors is highly desirable. In this study, we built an extensive data set consisting of 20 888 FLuc inhibitors and 198 608 noninhibitors, and then developed a group of classification models based on the combination of three machine learning (ML) algorithms and four types of molecular representations. The best prediction model based on XGBoost and ECFP4 and MOE2d descriptors yielded a balanced accuracy (BA) of 0.878 and an area under the receiver operating characteristic curve (AUC) value of 0.958 for the validation set, and a BA of 0.886 and an AUC of 0.947 for the test set. Three external validation sets, including set 1 (3231 FLuc inhibitors and 69 783 noninhibitors), set 2 (695 FLuc inhibitors and 75 913 noninhibitors), and set 3 (1138 FLuc inhibitors and 8155 noninhibitors), were used to verify the predictive ability of our models. The BA values for the three external validation sets given by the best model are 0.864, 0.845, and 0.791, respectively. In addition, the important features or structural fragments related to FLuc inhibitors were recognized by the Shapley additive explanations (SHAP) method along with their influences on predictions, which may provide valuable clues to detecting undesirable luciferase inhibitors. Based on the important and explanatory features, 16 rules were proposed for detecting FLuc inhibitors, which can achieve a correction rate of 70% for FLuc inhibitors. Furthermore, a comparison with existing prediction rules and models for FLuc inhibitors used in virtual screening verified the high reliability of the models and rules proposed in this study. We also used the model to screen three curated chemical databases, and almost 10% of the molecules in the evaluated databases were predicted as inhibitors, highlighting the potential risk of false positives in luciferase-based assays. Finally, a public web server called ChemFLuc was developed (http://admet.scbdd.com/chemfluc/index/), and it offers a free available service to predict potential FLuc inhibitors.

Identification of 2-Benzylidene-tetralone Derivatives As Highly Potent and Reversible Firefly Luciferase Inhibitors.

Discovery of a series of 2-phenylnaphthalenes as firefly luciferase inhibitors

Mechanism-based Design of a Photoactivatable Firefly Luciferase.

Synthesis and biological evaluation of a series of aryl triazoles as firefly luciferase inhibitors

Identification and Synthesis of Substituted Pyrrolo[2,3-D]pyrimidines As Novel Firefly Luciferase Inhibitors

Inhibiting Firefly Bioluminescence by Chalcones

Biosynthetic Bifunctional Enzyme Complex with High-Efficiency Luciferin-Recycling to Enhance the Bioluminescence Imaging

Cybluc: an Effective Aminoluciferin Derivative for Deep Bioluminescence Imaging

Discovery of Alkene-Conjugated Luciferins for Redshifted and Improved Bioluminescence Imaging in Vitro and in Vivo.

False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.

Quenching the firefly bioluminescence by various ions

Fusion Expression of Bifunctional Enzyme Complex for Luciferin-Recycling to Enhance the Luminescence Imaging

A High-Throughput in Vivo Selection Method for Luciferase Variants

Structural Analysis and Identification of False Positive Hits in Luciferase-Based Assays.

Novel Furimazine Derivatives for Nanoluciferase Bioluminescence with Various C-6 and C-8 Substituents

Novel Caged Luciferin Derivatives Can Prolong Bioluminescence Imaging in Vitro and in Vivo.

Interaction of firefly luciferase with substrates and their analogs: a study using fluorescence spectroscopy methods

ferin derivatives can prolong bioluminescence imaging in vitro and in vivo †

Prolonged Bioluminescence Imaging in Living Cells and Mice Using Novel Pro-Substrates Forrenillaluciferase

Constructing Firefly Luciferin Bioluminescence Probes for in Vivo Imaging.

Computational investigation into the fluorescence of luciferin analogues